The introduction of modern, pan-genotypic direct acting antivirals (DAA’s) has revolutionised the treatment of HCV. As a result, the diagnostic testing algorithm has been simplified and hepatitis C genotyping is no longer necessary 1. However, many clinics and smaller hospital laboratories still lack the resources to perform confirmatory molecular testing and so are forced to send patient samples away for testing. Many patients have to wait weeks for their test results and often have to schedule a subsequent follow-up appointment at the local clinic.
Indirect patient cost is a significant burden. When samples are sent away for molecular testing, between 5-50% of patients do not return for their result and required treatment.2 The patient drop-out rate and indirect patient cost can be significantly reduced by performing the molecular confirmatory HCV test on-site using the Genedrive HCV ID Kit.
The Genedrive HCV ID Kit is a simple and cost effective molecular solution for HCV testing. The assay is ideal for use in low throughput, decentralised laboratories by providing rapid results direct from plasma without any requirement for viral RNA extraction.
If your laboratory has a low throughput and can not currently afford molecular testing, why not employ the Genedrive® HCV ID Kit!
The Genedrive® HCV ID Kit is:
Affordable
A cost effective solution for decentralised labs who are currently unable to afford HCV molecular testing.
Responsive
Complete the test, provide a confirmatory result and initiate patient treatment all in one visit, using a test and treat strategy